Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement

BACKGROUND: Olmesartan medoxomil (OLM), an anti-hypertensive agent administered orally has absolute bioavailability of only 26% due to the poor aqueous solubility (<7.75 μg/ml). The present investigation aimed at enhancing the oral bioavailability of OLM by improving its solubility and dissolutio...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakkar, Hetal Paresh, Patel, Bindesh Vishnubhai, Thakkar, Sneha Piyush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications Pvt Ltd 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178951/
https://www.ncbi.nlm.nih.gov/pubmed/21966165
http://dx.doi.org/10.4103/0975-7406.84459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178951/
https://www.ncbi.nlm.nih.gov/pubmed/21966165
http://dx.doi.org/10.4103/0975-7406.84459

Ejemplares similares